Erdosteine clinical trials
How each study uses erdosteine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the erdosteine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Erdosteine
- 5
Studies by the year they started
5 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 3
Adams Respiratory Therapeutics (1) · Pierachille Santus, MD, PhD (1) · Tanta University (1) · Edmond Pharma (1) · Hull University Teaching Hospitals NHS Trust (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test erdosteine.
- Nov 2026Erdosteine in the Treatment of Nonalcoholic Fatty Liver DiseasePhase 1/2 · Tanta University
- Feb 2027Immuno-inflammatory Response of Erdosteine in COPDNot applicable · Pierachille Santus, MD, PhD
Studies
Open first, then newest update. How each study uses erdosteine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Immuno-inflammatory Response of Erdosteine in COPDNot yet recruitingNot applicablePierachille Santus, MD, PhDNCT07329946Written as Erdosteine
- Erdosteine in the Treatment of Nonalcoholic Fatty Liver DiseaseRecruitingPhase 1/2Tanta UniversityNCT07242222Written as Erdosteine
- Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)WithdrawnPhase 4Hull University Teaching Hospitals NHS TrustNCT01176318Written as Erdosteine
- The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD)Status unknownPhase 3Edmond PharmaNCT01032304Written as Erdosteine
- Phase 2 Study - Erdosteine in Patients With CB/COPDCompletedPhase 2Adams Respiratory TherapeuticsNCT00338507Written as Erdosteine
Codes
What other systems call erdosteine · ClinicalTrials.gg INT003269
- MeSH (NLM) C048498erdosteineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 76J0853EKAERDOSTEINEConfirmed FDA, NLM, Wikidata
- RxNorm 24305Confirmed FDA, Wikidata
- Wikidata Q3731252erdosteineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61750ErdosteineOne source FDA
- DrugBank DB05057One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C048498 | erdosteine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 76J0853EKA | ERDOSTEINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 24305 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3731252 | erdosteine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61750 | Erdosteine | One source FDA |
| DrugBank | DB05057 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.